Cite

HARVARD Citation

    Tanaka, H. et al. (2018). Long‐term retention of adalimumab treatment and associated prognostic factors for 1189 patients with Crohn's disease. Journal of gastroenterology and hepatology. 33 (5), pp. 1031-1038. [Online]. 
  
Back to record